T-cells are a type of white blood cell that circulate around our bodies, looking for abnormalities and infections. Specific to cancer and disease, t-cells search for and find infected or cancerous cells to kill. Sometimes, however, cancer cells are able to evade t-cells to become life-threatening conditions.

Today, doctors are able to collect t-cells from cancer patients, modify them in a lab, and place them back into their cancer patients’ bodies so that the t-cells target and kill cancer. This ground-breaking process, called CAR-T therapy, has lead to thousands of cancer patients entering remission. Many of these patients, who literally thought they only had a matter of months to live, have been able to return to their normal, everyday lives.

Unfortunately, no. Some patients get approved for cancer treatments using t-cells only to learn that they don’t have enough t-cells in their body to collect. Many patients who fall into this group have undergone extensive radiation, chemotherapy, or other treatments that have wiped their bodies of their functioning t-cells. If this happens, there is little or nothing left for a cancer patient to do. Their fight is essentially over.

At Cell Vault, we want to prevent this situation from happening by ensuring individuals bank their t-cells before they’re diagnosed or undergo treatments – such as chemotherapy – that may wipe out their t-cells.

The FDA has approved the use of CAR-T therapy for certain acute lymphoblastic leukemia (ALL) or diffuse large B-cell lymphoma (DLBCL) diagnoses. Additionally, billions of dollars are being invested across thousands of t-cell related clinical trials. Doctors are optimistic that t-cells will be instrumental in beating many other cancers and diseases in the near future. These cancers could include Multiple Myeloma, breast cancer, lung cancer, and brain cancer, to name a few.

Healthy individuals should bank their cells while their cells are functional and plentiful. The sooner, the better because an individual’s t-cells decrease in number and functionality as they age.

As soon as possible. Because your cells decrease in strength, viability, and number as you age, you will never be in a better position than you are right now to bank your cells. Moreover, if cancer cells begin to grow, this deterioration process accelerates. We recommend banking the healthiest version of yourself, today, to give yourself the best chance of beating the cancers and diseases of tomorrow.


Below, we’ve included interviews from many cancer survivors who are grateful to be alive thanks to their t-cells. Click on each video to hear how their t-cells were used to battle and kill cancer from within.

Omaha Firefighter Receives CAR-T Therapy

33 year old firefighter, Nick Howe, from Omaha, NE, was diagnosed with cancer after discovering a lump on his neck. His treatments lead him down a path that resulted in extensive weight loss, a stem cell transplant, and chemotherapy. Once he started CAR-T, he sailed through the treatment and had a spectacular response that surprised both him and his doctors. 

Tanis’s Immunotherapy Story

After treatment for non-Hodgkin’s lymphoma, Tanis had been in remission for years. But when her cancer returned, she turned to Mayo Clinic and a new, individualized cell-based therapy known as CAR-T Cell Therapy. Today, Tanis is well and living life to the fullest.

UCLA’s first CAR T Clinical Trial Is a Success

Denise Delatorre felt a lump in her stomach that she knew was serious. She was diagnosed with non-Hodgkin’s lymphoma, one of the most common blood cancers. When chemotherapy didn’t work, she enrolled in UCLA’s first CAR T clinical trial. Today, Denise is in sustained remission. This is her story.

CAR T-cell Therapy: Scott McIntyre's Story

After many treatments for stage 3 diffuse B-cell lymphoma failed, Scott McIntyre of South Bend, Ind., became the first patient to undergo CAR T-cell gene therapy in a clinical trial at the University of Chicago Medicine. Scott McIntyre was given a life expectancy of 6 months. He received CAR-T therapy in 2017. On the next scan, he was cancer-free and he is still in 100% remission.

Getting Through Leukemia Together: Karen's Immunotherapy Story

When Karen Koehler’s chronic lymphocytic leukemia (CLL) transitioned into high gear, she knew she wanted to look beyond the standard treatment options. “Why can’t this [CAR-T Therapy] be the cure?” “Your body is supposed to fight the cancer to begin with. So when it doesn’t, why not reengineer the cells to tell them what to do?”

Stephanie Florence Successfully Treated with CAR T-cell Therapy

At 32, lymphoma patient, Stephanie Florence thought her “days were numbered.” She pinned her hopes on a new immunotherapy clinical trial, CAR T therapy. Just 28 days later, she was in complete remission. This is the miracle the Idaho woman was waiting for.